Aristo Bio-Tech And Lifescience Limited — Others, 14-08-2025: Appointment

Aristo Bio-Tech and Lifescience's board has approved a final dividend of Rs. 0.5 per equity share for FY2024-25, with September 1 set as the record date for eligibility. The company will hold its 20th Annual General Meeting virtually on September 8 to approve the Directors’ Report and other key matters. The board also approved the re-appointment of Prakash Chandra Jain & Co. as Statutory Auditors for another four years, pending shareholder approval at the AGM, and appointed Y.S. Thakar & Co. as Cost Auditors for FY2025-26. These steps ensure ongoing corporate governance and shareholder returns.